User Form | JAZ-157925M IP

Vote ID

This symposium is organised and funded by Jazz Pharmaceuticals for healthcare professionals specialised and experienced in the management of haematopoietic stem cell transplantation (HSCT).
Prescribing information and adverse event reporting information can be found at the bottom of this page.
Jazz Pharmaceuticals’ product(s) will be discussed in line with the EU Marketing Authorisation, which may not be registered in all countries.

Register your interest now

Jazz Pharmaceuticals is delighted to invite you to attend their sponsored symposium at EBMT 2025 entitled 'Past, Present and Future: why hypervigilance for hepatic VOD remains critical'.

To find out more about the symposium, please scroll down to hear from our Chair.

* Required field

Email

Phone Number

First Name

Last Name

Role at work place

Primary speciality

Name of your practice

Country of practice

City of practice

We would like you to register your interest so we may share more information regarding the Jazz-sponsored symposium as well as corporate and promotional communications from Jazz Pharmaceuticals. If you would like to register your interest, please complete the below.

Please confirm how you would like to receive these communications?

Which therapy area would you like to hear more about?

Promotional Material

Hematology/Oncology

Neurosciences-Epilepsy

Adverse events should be reported. Healthcare professionals are asked to report any suspected adverse events via their national reporting system. For the UK, reporting forms and information can be found at yellowcard.mhra.gov.uk, or search for Yellow Card MHRA in the Google Play or Apple App Store. Adverse events should also be reported to Jazz Pharmaceuticals at AEreporting@jazzpharma.com